SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Haoxi Health Technology Ltd
Date: June 9, 2025 · CIK: 0001954594 · Accession: 0000000000-25-006038

Regulatory Compliance Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-287686

Date
June 9, 2025
Author
Division of
Form
UPLOAD
Company
Haoxi Health Technology Ltd

Letter

Re: Haoxi Health Technology Ltd Registration Statement on Form F-3 Filed May 30, 2025 File No. 333-287686 Dear Zhen Fan:

June 9, 2025

Zhen Fan Chief Executive Officer Haoxi Health Technology Ltd Room 801, Tower C, Floor 8 Building 103, Huizhongli Chaoyang District, Beijing China

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Nicholas Nalbantian at 202-551-7470 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Trade &
Services
cc: Joan Wu

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 June 9, 2025

Zhen Fan
Chief Executive Officer
Haoxi Health Technology Ltd
Room 801, Tower C, Floor 8
Building 103, Huizhongli
Chaoyang District, Beijing
China

 Re: Haoxi Health Technology Ltd
 Registration Statement on Form F-3
 Filed May 30, 2025
 File No. 333-287686
Dear Zhen Fan:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Nicholas Nalbantian at 202-551-7470 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Trade &
Services
cc: Joan Wu
</TEXT>
</DOCUMENT>